TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KURA

Kura Oncology Inc

Healthcare · Biotechnology

10.80$ -0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement KURA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – 100.0% 100.0%
– – – – – – – – – – 1.6% 0.1%
– – – – – – – – – – 100.0% 99.9%
– – – – – – – – – – 315.4% 372.1%
– – – – – – – – – – 143.1% 177.8%
– – – – – – – – – – 458.5% 549.9%
– – – – – – – – – – -358.5% -449.9%
– – – – – – – – – – 3.0% 2.2%
– – – – – – – – – – -319.1% -412.5%
– – – – – – – – – – 3.7% 0.4%
– – – – – – – – – – -322.9% -412.9%
– – – – – – – – – – -314.6% -408.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?